WorldQuant Millennium Advisors
EW icon

WorldQuant Millennium Advisors’s Edwards Lifesciences EW Stock Holding History

WorldQuant Millennium Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.7M Sell
270,554
-182,012
-40% -$15M 0.08% 214
2025
Q4 		$38.6M Buy
+452,566
New +$37.1M 0.15% 157
2025
Q3 		– Sell
-336,507
Closed -$26.3M – 553
2025
Q2 		$26.3M Sell
336,507
-25,692
-7% -$1.92M 0.13% 178
2025
Q1 		$26.3M Sell
362,199
-363,805
-50% -$26M 0.17% 159
2024
Q4 		$53.7M Buy
726,004
+125,487
+21% +$8.78M 0.35% 83
2024
Q3 		$39.6M Buy
+600,517
New +$43.6M 0.29% 101
2024
Q1 		– Sell
-14,925
Closed -$1.14M – 371
2023
Q4 		$1.14M Sell
14,925
-140,957
-90% -$9.81M 0.02% 293
2023
Q3 		$10.8M Sell
155,882
-256,530
-62% -$20.6M 0.17% 165
2023
Q2 		$38.9M Sell
412,412
-90,199
-18% -$7.84M 0.66% 33
2023
Q1 		$41.6M Sell
502,611
-503,893
-50% -$39.6M 0.77% 27
2022
Q4 		$75.1M Buy
1,006,504
+451,823
+81% +$34.8M 1.71% 2
2022
Q3 		$45.8M Buy
554,681
+499,104
+898% +$48M 1.11% 17
2022
Q2 		$5.29M Sell
55,577
-13,309
-19% -$1.38M 0.15% 183
2022
Q1 		$8.11M Sell
68,886
-28,978
-30% -$3.25M 0.2% 164
2021
Q4 		$12.7M Buy
97,864
+73,821
+307% +$8.61M 0.25% 135
2021
Q3 		$2.72M Buy
+24,043
New +$2.74M 0.06% 245
2021
Q2 		– Sell
-77,292
Closed -$6.46M – 359
2021
Q1 		$6.46M Hold
77,292
– – 0.14% 207
2020
Q4 		$7.05M Sell
77,292
-25,547
-25% -$2.12M 0.15% 200
2020
Q3 		$8.21M Sell
102,839
-80,468
-44% -$6.28M 0.19% 158
2020
Q2 		$12.7M Sell
183,307
-19,769
-10% -$1.4M 0.29% 115
2020
Q1 		$12.8M Buy
+203,076
New +$14.6M 0.31% 108
2018
Q4 		– Sell
-52,878
Closed -$3.07M – 314
2018
Q3 		$3.07M Buy
52,878
+1,770
+3% +$86.6K 0.1% 186
2018
Q2 		$2.48M Buy
+51,108
New +$2.39M 0.1% 190

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

WorldQuant Millennium Advisors's EW Position: Q1 2026 in Review

WorldQuant Millennium Advisors reduced its Edwards Lifesciences (EW) stake by 40% in Q1 2026, selling an estimated $15M and leaving 270,554 shares worth $21.7M. The position accounts for 0.08% of the portfolio, ranked #214.

WorldQuant Millennium Advisors first reported a position in EW in Q2 2018 and has held it in 23 quarters since. The position peaked at $75.1M in Q4 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • WorldQuant Millennium Advisors held 270,554 shares of Edwards Lifesciences worth $21.7M as of Q1 2026.
  • WorldQuant Millennium Advisors sold 182,012 Edwards Lifesciences shares in Q1 2026, an estimated $15M.
  • Edwards Lifesciences made up 0.08% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #214 holding.
  • WorldQuant Millennium Advisors first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 23 quarters since.
  • WorldQuant Millennium Advisors's Edwards Lifesciences position peaked at $75.1M in Q4 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.